A. D. Yalcin And A. N. YALÇIN, "Future perspective: biologic agents in patients with severe COVID-19," IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.43, no.1, pp.1-7, 2021
Yalcin, A. D. And YALÇIN, A. N. 2021. Future perspective: biologic agents in patients with severe COVID-19. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.43, no.1 , 1-7.
Yalcin, A. D., & YALÇIN, A. N., (2021). Future perspective: biologic agents in patients with severe COVID-19. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.43, no.1, 1-7.
Yalcin, Arzu, And ATA NEVZAT YALÇIN. "Future perspective: biologic agents in patients with severe COVID-19," IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.43, no.1, 1-7, 2021
Yalcin, Arzu D. And YALÇIN, ATA N. . "Future perspective: biologic agents in patients with severe COVID-19." IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.43, no.1, pp.1-7, 2021
Yalcin, A. D. And YALÇIN, A. N. (2021) . "Future perspective: biologic agents in patients with severe COVID-19." IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.43, no.1, pp.1-7.
@article{article, author={Arzu Didem Yalcin And author={ATA NEVZAT YALÇIN}, title={Future perspective: biologic agents in patients with severe COVID-19}, journal={IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY}, year=2021, pages={1-7} }